Molecular Imaging for Integrated Medical Therapy and Drug Development
Buch in deiner Nähe kaufen
Beschreibung
Molecular imaging plays an important role in drug discovery and advanced medical practice. A symposium of world leaders in drug research and development, molecular imaging, and medical therapy including regenerative treatment and radiation therapy has led to the publication of this book. Based on the proceedings of the symposium, many excellent ideas and valuable discussions are introduced that will guide the reader toward new advances in photon detection and protein modification as well as new developments in molecular imaging itself. Both protein modification and photon detection are emerging technologies that hold forth the promise of innovative strategies for drug discovery and medical care. The publication of these proceedings is a timely means of sharing significant experience and knowledge with many specialists all over the world. This book will be of great value to a wide variety of researchers in the fields of drug development and molecular imaging technologies, leading to integrated medical therapy and progress in human health.
Helpful for understanding new advances of photon detection, molecular imaging, and also protein modification, leading to integrated medical therapy and future drug development
Autor*in
Nagara Tamaki
Themen in »Molecular Imaging for Integrated Medical Therapy and Drug Development«
Integrated medical therapy. brain drug drug development drug discovery drug research imaging molecular imaging radiation radiotherapy research
Stimmen zu »Molecular Imaging for Integrated Medical Therapy and Drug Development«
From the reviews:
“The book is divided into 4 parts and 28 presentations, with multiple authors for each presentation, and an introductory overview by the editors on advances in molecular imaging. … This book is intended for researchers involved in molecular imaging or drug development and clinicians who treat patients with or without cancer. The material will be useful to individuals familiar with this discipline and those who are new to this discipline and will likely be involved with personalized medical care.” (Aurelio Matamoros, Jr., The Journal of Nuclear Medicine, Vol. 53 (7), July, 2012)()